SCGB1C1: A Potential Drug Target Or Biomarker (G147199)

Target Name: SCGB1C1

NCBI ID: G147199

SCGB1C1

SCGB1C1: A Potential Drug Target Or Biomarker

SCGB1C1, also known as secretoglobin RYD5, is a protein that is expressed in various tissues throughout the body, including the brain, heart, kidneys, and liver. It is a member of the secretoglobin family, which consists of a variety of proteins that are involved in the transport of proteins from the cell surface to the interior of the cell.

One of the unique features of SCGB1C1 is its ability to interact with and modulate the activity of other proteins. This interaction with other proteins makes it a potential drug target or biomarker, as the disruption of its function could have a significant impact on the cell's ability to function properly.

The secretoglobin family of proteins plays a crucial role in the regulation of intracellular protein levels and their transport to the cell's interior. SCGB1C1 is involved in this process, as it has been shown to interact with and modulate the activity of other proteins involved in protein trafficking, such as the transmembrane protein known as T-cell antigen 4 (TMA4) and the endoplasmic reticulum-resident protein known as calbindin.

SCGB1C1's interaction with TMA4 has been shown to play a role in the regulation of T-cell antigen 4-mediated signaling pathways, which are involved in the regulation of T-cell activation and proliferation. Similarly, its interaction with calbindin has been shown to contribute to the regulation of calbindin-mediated signaling pathways that are involved in the regulation of cell adhesion, migration, and invasion.

These findings suggest that SCGB1C1 is a potential drug target or biomarker for a variety of diseases, as disruptions in its function could have a significant impact on the regulation of intracellular protein levels and their transport to the cell's interior.

In addition to its potential as a drug target or biomarker, SCGB1C1 also has potential as a diagnostic tool. The ability of this protein to interact with and modulate the activity of other proteins makes it a promising candidate for use in disease diagnosis and treatment. For example, disruptions in SCGB1C1 function could be used as a biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In conclusion, SCGB1C1 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Its interaction with other proteins and its ability to modulate the activity of these proteins make it a promising candidate for use in disease diagnosis and treatment. Further research is needed to fully understand its function and its potential as a drug or biomarker.

Protein Name: Secretoglobin Family 1C Member 1

The "SCGB1C1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCGB1C1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets